Ganeden will discuss new probiotic product launches in the food, beverage, personal care and companion animal spaces using the company’s patented ingredients during Vitafoods Europe at Booth D65. The team will also introduce details regarding the launch of a new and industry-changing immune-health ingredient, provide information on new published research, release probiotic educational content, and make announcements regarding certifications and regulatory work.
The probiotic supplier has been making international headlines with its continued advancements in science, ingredient technology and innovative product launches. Best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented and highly stable probiotic ingredient that can be found in more than 750 products worldwide, Ganeden has also made headway in the personal care space with Bonicel, the first probiotic-derived personal care ingredient shown to dramatically reduce seven signs of aging.
“Probiotic technology is a top trend that is becoming a driving force in the natural products and nutraceuticals spaces globally,” said Michael Bush, president and CEO of Ganeden. “Our science and innovation has allowed us to expand our ingredient lineup and availability internationally to meet this demand, allowing manufacturers of virtually any product the opportunity to formulate using this technology to offer a variety of health benefits.”
Some of Ganeden’s noteworthy announcements being discussed at the show include:
Ganeden recently announced the launch of a new immune-health ingredient branded as Staimune (Inactivated Bacillus coagulans GBI-30, 6086). The patented ingredient utilizes the cell walls of the GanedenBC30 probiotic strain which have been shown to support immune health, at cost effective inclusion levels that will not alter flavor or texture profiles. Available this summer, Ganeden anticipates Staimune to be an industry-changing development. This new ingredient is FDA GRAS, non-GMO, organic compliant and kosher, allowing it to go into virtually any food or beverage application, including shelf stable beverages and baked goods.
Ganeden’s two most recent studies have been accepted for publication in peer-reviewed journals, increasing the company’s total number of published studies to 26. The research further supports the science backing GanedenBC30, with one of the studies highlighting the strain’s unique effects on protein utilization. The published papers are being added to a long list of research showing the benefits, safety and efficacy of the strain. Ganeden will also be continuing its ongoing research, with multiple additional study results on various benefits becoming available later this year.
Ganeden continues to lead the industry in terms of educational outreach and regulatory work. Ganeden’s international regulatory experts work with government officials around the world to receive approvals to sell probiotic ingredients, leading to GanedenBC30‘s availability in 66 countries. In addition, the team continues to release educational content, for industry leaders and consumers, addressing the most common probiotic misconceptions.
New Probiotic Launches
Ganeden is working with some of the world’s top food and beverages companies to help launch new probiotic products, including unique formulations into a variety of new food and beverage categories. More details on recent launches will be available at the Vitafoods show, which include some large CPG companies in the U.S., the first beverage launch in China and a food launch in India.